Survodutide 10mg Bali | Research Peptide | Atlas Longevity
Rp2,200,000.00 ~$133.33
Survodutide 10mg is an investigational dual glucagon receptor (GCGR) and GLP-1 receptor agonist being studied in metabolic and weight-management research.
✓ 10mg Survodutide
✓ Dual GCGR/GLP-1 receptor agonist
✓ Metabolic research compound
✓ Premium Atlas Longevity quality
✓ COA available where applicable
✓ Discreet packaging
✓ Fast delivery across Bali
For research purposes only.
Use code WELCOME20 at checkout. Valid for the first 100 orders only.
Available on backorder
- COA Verified
- Same-Day Dispatch
- Ships from Bali
- SSL Secure
Survodutide 10mg Bali
Survodutide is an investigational peptide-based compound designed to activate both the glucagon receptor and GLP-1 receptor.
Its dual-receptor mechanism has made it an important compound in current research involving body-weight regulation, energy metabolism and metabolic health.
Survodutide has progressed into human clinical trials, but it remains investigational and should not be presented as an approved weight-loss treatment.
Atlas Longevity supplies Survodutide 10mg with premium service and discreet delivery throughout Bali.
What Is Survodutide?
Survodutide is a dual GCGR/GLP-1 receptor agonist.
GLP-1 receptor activation is associated with appetite, satiety and glucose-related signalling, while glucagon receptor activation is involved in energy and metabolic regulation.
Researchers are investigating whether targeting both pathways can provide complementary metabolic effects.
Research Areas
Survodutide is being investigated in areas including:
• Body-weight regulation
• Appetite and satiety signalling
• Energy metabolism
• GLP-1 receptor signalling
• Glucagon receptor signalling
• Metabolic health
• Obesity research
These research areas should not be interpreted as guaranteed results or approved therapeutic indications.
Survodutide vs Semaglutide
The compounds target different receptor pathways.
Semaglutide:
GLP-1 receptor agonist
Survodutide:
Dual glucagon/GLP-1 receptor agonist
Survodutide therefore adds glucagon-receptor activity alongside GLP-1 receptor activity.
Survodutide vs Retatrutide
Survodutide and Retatrutide are both investigational multi-receptor compounds, but they are different.
Survodutide:
GCGR + GLP-1
Retatrutide:
GIP + GLP-1 + GCGR
Retatrutide is therefore generally described as a triple receptor agonist, while Survodutide is a dual receptor agonist.
Product Details
Compound: Survodutide
Strength: 10mg
Format: Lyophilised vial
Brand: Atlas Longevity
Quality & COA
Atlas Longevity focuses on premium, quality-controlled products.
Batch documentation and COAs are available where applicable and may provide information relating to:
• Product identity
• Batch information
• Purity
• Analytical testing
Contact Atlas Longevity for the latest available batch documentation.
Storage
Store according to the instructions supplied with the current batch.
Protect from excessive heat, direct sunlight, moisture, contamination and unnecessary temperature fluctuations.
Delivery Across Bali
Atlas Longevity is a delivery-only service.
Around Canggu: 50,000 IDR
All other areas of Bali: 100,000 IDR
Fast and discreet delivery is available across Canggu, Seminyak, Ubud, Uluwatu, Sanur, Denpasar, Jimbaran, Nusa Dua and surrounding areas.
Why Atlas Longevity?
✓ Premium quality
✓ COAs where applicable
✓ Discreet packaging
✓ Fast Bali delivery
✓ Professional customer support
✓ Support before and after your order
FAQ
What is Survodutide?
Survodutide is an investigational dual glucagon receptor and GLP-1 receptor agonist being studied for metabolic and body-weight-related applications.
How does Survodutide work?
Survodutide is designed to activate both the glucagon receptor (GCGR) and GLP-1 receptor, targeting two different metabolic signalling pathways.
Is Survodutide the same as Semaglutide?
No. Semaglutide targets the GLP-1 receptor, whereas Survodutide targets both GLP-1 and glucagon receptors.
What is the difference between Survodutide and Retatrutide?
Survodutide is a dual GCGR/GLP-1 receptor agonist. Retatrutide targets three receptors: GIP, GLP-1 and glucagon.
How much Survodutide is in each vial?
Each vial contains 10mg of Survodutide.
Is Survodutide approved for weight loss?
Survodutide remains an investigational compound and should not be presented as an approved weight-loss treatment.
Is a COA available?
Batch documentation and COAs are available where applicable. Contact Atlas Longevity for current batch documentation.
Can I order Survodutide in Bali?
Yes. Atlas Longevity provides Survodutide 10mg with discreet delivery throughout Bali, subject to current stock availability.
Disclaimer
For lawful research purposes only. Not intended for human or animal consumption. Not intended to diagnose, treat, cure or prevent any medical condition.














